ASX - By Stock
|
SNT |
Re:
Ann: SNT to Trial New Cancer Indication Following MRFF Grant
|
|
ohisay
|
8 |
3.5K |
0 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
8
|
3.5K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change in substantial holding
|
|
ohisay
|
12 |
4.1K |
3 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
12
|
4.1K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change in substantial holding
|
|
ohisay
|
12 |
4.1K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
12
|
4.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Syntara Receives $5m R&D Tax Incentive
|
|
ohisay
|
4 |
1.3K |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
4
|
1.3K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Company Restructure Sale of Mannitol Business
|
|
ohisay
|
12 |
4.4K |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
12
|
4.4K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
News: PXS Pharmaxis Seeks Trading Halt
|
|
ohisay
|
7 |
2.4K |
5 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
7
|
2.4K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Final Set of Interim Data from PXS-5505 in Myelofibrosis
|
|
ohisay
|
7 |
3.1K |
1 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
|
|
ohisay
|
15 |
7.7K |
0 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
15
|
7.7K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
|
|
ohisay
|
15 |
7.7K |
2 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
15
|
7.7K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
|
|
ohisay
|
15 |
7.7K |
5 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
15
|
7.7K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study
|
|
ohisay
|
15 |
7.7K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
15
|
7.7K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Quarterly Update and Investor Briefing
|
|
ohisay
|
1 |
694 |
0 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
1
|
694
|
0
|
|
ASX - By Stock
|
SNT |
Re:
News: PXS Pharmaxis Plans To Commence Trial Of Combination Therapy In 2023
|
|
ohisay
|
9 |
3.8K |
3 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
9
|
3.8K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Drug Study Published in Nature Communications
|
|
ohisay
|
8 |
3.2K |
0 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Drug Study Published in Nature Communications
|
|
ohisay
|
8 |
3.2K |
0 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation
|
|
ohisay
|
1 |
991 |
0 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
1
|
991
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Skin Scarring Study Fully Recruited
|
|
ohisay
|
1 |
1.1K |
0 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
1
|
1.1K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change in substantial holding
|
|
ohisay
|
3 |
1.1K |
1 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
3
|
1.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ohisay
|
4 |
2.0K |
2 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
4
|
2.0K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: R&D Showcase Presentations Webinar 2
|
|
ohisay
|
8 |
5.6K |
4 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
8
|
5.6K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - PXS
|
|
ohisay
|
2 |
1.2K |
3 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
2
|
1.2K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Appendix 2A - Exercise of Employee Options
|
|
ohisay
|
7 |
2.2K |
0 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: First Patient Enrolled - Clinical Trial for Cancer Treatment
|
|
ohisay
|
16 |
9.1K |
0 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
16
|
9.1K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: First Patient Enrolled - Clinical Trial for Cancer Treatment
|
|
ohisay
|
16 |
9.1K |
0 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
16
|
9.1K
|
0
|
|
ASX - By Stock
|
SNT |
Gruesome or what?
|
|
ohisay
|
2 |
88K |
1 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
2
|
88K
|
1
|
|
ASX - By Stock
|
FAR |
Re:
Malcy
|
|
ohisay
|
31 |
904K |
1 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
31
|
904K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed Issue of Securities to CEO
|
|
ohisay
|
9 |
6.4K |
5 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
9
|
6.4K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Pharmaxis shareholders breathe easy – the FDA loves you
|
|
ohisay
|
16 |
13K |
4 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
16
|
13K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Stockheads take.
|
|
ohisay
|
3 |
1.8K |
0 |
23/07/19 |
23/07/19 |
ASX - By Stock
|
3
|
1.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Where’s Bakkie
|
|
ohisay
|
3 |
2.3K |
0 |
31/01/19 |
31/01/19 |
ASX - By Stock
|
3
|
2.3K
|
0
|
|
ASX - By Stock
|
SNT |
Dr Kathleen Metters
|
|
ohisay
|
1 |
1.2K |
10 |
22/05/18 |
22/05/18 |
ASX - By Stock
|
1
|
1.2K
|
10
|
|
ASX - By Stock
|
PCL |
Re:
Tullow....
|
|
ohisay
|
5 |
3.7K |
0 |
06/11/14 |
06/11/14 |
ASX - By Stock
|
5
|
3.7K
|
0
|
|
ASX - By Stock
|
PCL |
Re:
Tullow....
|
|
ohisay
|
5 |
3.7K |
0 |
06/11/14 |
06/11/14 |
ASX - By Stock
|
5
|
3.7K
|
0
|
|